BRCA1 testing: Some issues in moving from research to service

Psycho-Oncology

Volumn 5, Issue 3, 1996, Pages 223-232

  Ponder, Maggie ^a   Green, Josephine M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; MEDICAL PSYCHOLOGY; ONCOGENE; OVARY CANCER;

EID: 0029793727     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1611(199609)5:3<223::AID-PON237>3.0.CO;2-X     Document Type: Article

References (33)

1. Arnesson, L. G., Vitak, B., Manson, J. C., Fagerberg, (J. and Smeds, S. (1995) Diagnostic outcome of repeated mammography screening. World J. Surg. 19, 372-8.
2. Claus, E. B., Risch, N. J. and Thompson, W. D. (1993) Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131, 961-972.
3. Chaliki, H., Loader, S., Levenkron J., Logan-Young W., Hall, W. and Rowley, P. (1995) Women's receptivity to testing for genetic susceptibility. Am. J. Public Health 85(8), 1133-1135.
4. Craufurd, D., Dodge, A., Kerzin-Storrar, L. and Harris, R. (1989) Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 2, 603-05.
5. Dudok de Wit A. C., Meijers-Heijboer E. J., Tibben A., Frets P. G., Klijn, J. G. M., Devilee, P. and Niermeijer, M. F. (1994) Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer. Lancet 344, 197.
6. Easton, D. F., Narod, S. A., Ford, D. and Steel, M. (1934) The genetic epidemiology of BRCA1. Lancet 344, 761.
7. Evans, D. G. R., Fentiman, I. S., McPherson, K., Asbury, D., Ponder, B. A. J. and Howell, A. (1994) Familial breast cancer. BMJ 308, 183-187.
8. Farrant, W. (1985) 'Who's for amniocentesis?' The politics of prenatal screening, in The Sexual Politics of Reproduction, (H. Homans Ed.) Gower, London.
9. Ford, D., Easton, D. F., Bishop. D. T., Narod, S. A., Goldgar, D. E. and the Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343, 692-695.
10. Gayther, S. A., Mazoyer, S., Warren, W., Russell, P. A., Harrington, P. A., Chiano M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A., Love, R., Evans,G., Easton, D., Clayton, D., Stratton, M. R. and Ponder, B. A. J. (1995) Germline mutations of the BRCA1 gene in breast/ovarian cancer families: evidence for a. phenotype-genotype correlation. Nature Genetics 11, 428-433.
11. Green, J. M. (1995) Making sense of a family history of cancer. Paper given to the Institute of Biology National Conference. Edinburgh 8th April, 1995.
12. Green, J., Murton, F. and Statham, H. (1993) Psychological issues raised by a familial ovarian cancer register. J. Med. Genet. 30, 101-105.
13. Green, J., Richards, M., Statham, H., Murton, F. and Hallowell, N. (1996) Family communication and genetic counselling: the case of hereditary breast and ovarian cancer. Submitted for publication.
14. House of Commons Science and Technology Committee (1995) Human Genetics: the Science and its Consequences. 3rd report. HMSO.
15. Kash, K. M., Holland, J. C., Halper, M. S. and Miller D. G. (1992) Psychological distress and surveillance behaviours of women with a family history of breast cancer. J. Natl. Cancer Inst. 84(1), 24-30.
16. King, M. C., Rowell, S. and Love, S. M. (1993) Inherited breast and ovarian cancer. What are the risks? What are the choices.? JAMA 269, 1975-1980.
17. Lerman, C., Daly, M., Masny, A. and Balshem A. (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol. 12(4), 843-850.
18. Lerman, C., Seay, J., Balshem, A. and Audrain, J. (1995) Interest in genetic testing among first degree relatives of breast cancer patients. Am. J. of Med. Genet. 57(3), 385-392.
19. Lynch, T. H. and Watson, P. (1992) Genetic counselling and hereditary breast/ovarian cancer. Lancet 339, 1181.
20. McPherson, K., Steel, C. M. and Dixon, J. M. (1994) Breast cancer - epidemiology, risk factors, and genetics. SMJ 309, 1003-1006.
21. Marteau, T. M., Kidd J., Cook, R., Johnston, M., Mitchie, S., Shaw, R. W. and Slack, J. (1988) Screening for Down's syndrome. BMJ 297, 1469.
22. Mikki, J., Swensen, J., Shattuck-eidens, D. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
23. NIH Consensus Development Panel on Ovarian Cancer. (1995) NIH Consensus Conference Ovarian Cancer Screening, Treatment, and Follow-up. JAMA 273, 491-497.
24. Nuffield Council on Bioethics (1993) Genetic Screening Ethical Issues.
25. Richards, M. P. M. (1996) Lay and Professional Knowledge of Genetics and Inheritance. Submitted for publication. Public Understand. Sci. 5, 217-230.
26. Richards, M. P. M. and Green, J. M. (1993) Issues raised by serum screening for fetal abnormality and detection of carriers of genetic disease: a discussion paper. J. Reprod. and Infant Psych. 11, 49-56.
27. Richards, M. P. M. and Pondes, M. (1996) Lay understanding of genetics: A test of an hypothesis. J. Med. Genet, (in press).
28. Struewing, J. P., Abeliocich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S. and Brody, L. C. (1995b) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 per cent in Ashkenizi Jewish individuals. Nature Genet. 11, 198-200.
29. Struewing, J. P., Lerman C., Kase, R. G., Giambarresi, T. R. and Tucker M. A. (1995a) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epid. Biomarkers Prev. 4, 169-73.
30. Super, M., Schwarz, M. J., Malone, G., Roberts, T., Haworth, A. and Dermody, G. (1994) Active cascade testing for carriers of cystic fibrosis gene. BMJ 308, 1462-1467.
31. Tyler, A., Ball D. and Craufurd, D. (1992) Presymptomatic testing for Huntington's disease in the United Kingdom. BMJ 304, 1593-96.
32. Watson, M., Murday, V., Lloyd S., Ponder B., Averill, D. and Eeles, R. (1995) Genetic testing in breast/ ovarian cancer (BRCA1) families. Lancet 346, 583.
33. Wooster, R., Bignell, G., Lancaster, J., Swift, S. et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.